| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.5M | — | -83.2% |
| Cost of Revenue | $1.4M | — | -83.2% |
| Gross Profit | $1.1M | — | -83.3% |
| R&D Expense | $75K | — | -83.3% |
| SG&A Expense | $767K | — | -50.2% |
| Operating Income | -$3.0M | — | -258.8% |
| Pre-tax Income | -$3.3M | — | -44.3% |
| Income Tax | $4K | — | -99.2% |
| Net Income | -$3.3M | — | -19.2% |
| EPS (Basic) | -$2.67 | — | -709.1% |
| EPS (Diluted) | -$2.67 | — | -709.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.5M | -25.8% | +84.8% |
| Accounts Receivable | $922K | -17.2% | -3.8% |
| Current Assets | $9.3M | -16.9% | -88.4% |
| Total Assets | $9.9M | -24.4% | -90.8% |
| Current Liabilities | $8.9M | -11.0% | -91.4% |
| Total Liabilities | $10.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.1M | — | +86.7% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $0 | — | +100.0% |
| Financing Cash Flow | $391K | — | -80.4% |
| Free Cash Flow | -$2.1M | — | +86.8% |
| -90.2% |
| Stockholders' Equity | -$972K | -245.5% | +68.5% |